Reference priceRUB ₽57,750.00Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Zelboraf Tablets |
|---|---|
| Manufacturer | ROCHE |
| Prescription required | Yes |
Zelboraf 240mg Filmtabletten,56ST x 1(vemurafenib)
VEMURAFENIB
Description
Zelboraf 240mg Filmtabletten,56ST x 1(vemurafenib) is a medicine catalog record in the MediPriceHub database. Active ingredient: VEMURAFENIB. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: ROCHE. Therapeutic category: Medicine Library > Oncology Medicines > Skin Cancer Medicines. Pack information: 240 / 56. Origin country or market: Germany. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
Limitation of Use: ZELBORAF is not indicated for treatment of patients with wild-type BRAF melanoma ZELBORAF ® is a kinase inhibitor indicated for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E mutation as detected by an FDA-approved test. ZELBORAF ® is indicated for the treatment of patients with Erdheim- Chester Disease with BRAF V600 mutation.How to Use
Use VEMURAFENIB under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: VEMURAFENIB. Pack size: 240 / 56. Pack unit: box. Manufacturer: ROCHE. Origin country: Germany. Source category: Medicine Library > Oncology Medicines > Skin Cancer Medicines. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Cancer medicines may cause fatigue, nausea, vomiting, diarrhea or constipation, appetite changes, mouth sores, rash, changes in blood counts, infection risk, liver or kidney test changes, bleeding risk, neuropathy, infusion reactions, or organ-specific toxicity depending on the medicine. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.Эта информация носит справочный характер. Перед применением лекарства проконсультируйтесь с медицинским специалистом.